Friday, May 12, 2023 12:30 PM – 1:15 PM ET Exhibit Hall D, Room 1
Exhibitor Workshop: Miltenyi Biotec
Unlock the Full Potential for Your CAR NK Cells
- Jonathan Druge, Jr., Immuno-oncology Applications
Natural killer (NK) cells are a promising tool in the fight against cancer. Allogeneic NK cells derived from suitable donors, showed high-clinical safety and impressive clinical outcomes in patients with acute myeloid leukemia (AML). Further engineering of NK cells with chimeric antigen receptors (CARs) bolsters their antitumor activity and mediates the specific killing of tumor cells. But despite substantial advances, unlocking the full therapeutic potential of CAR NK cells requires investigating their limited persistence, proliferation, and impaired in vivo antitumor activity. As a longtime trusted partner for cell and gene therapy solutions, Miltenyi Biotec is committed to advancing the CAR NK field. During this workshop, we will showcase how our most recent product developments and complete workflows can effectively advance your research and generate scalable and reproducible results. Get insight on how to isolate functional NK cells directly from your blood products, boost your lentiviral transduction efficiency, easily activate and expand your NK cells, and streamline your in-process and quality control (IPC/QC) methods with our latest flow analysis solutions. Join us and unlock the full potential of your CAR NK cells.